LSA
Lion Street Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Sell |
4,148
-220
| -5% | -$18.2K | 0.1% | 200 |
|
|
2025
Q1 | $354K | Sell |
4,368
-25
| -0.6% | -$2.03K | 0.11% | 186 |
|
|
2024
Q4 | $396K | Buy |
4,393
+450
| +11% | +$40.5K | 0.13% | 165 |
|
|
2024
Q3 | $390K | Sell |
3,943
-300
| -7% | -$29.6K | 0.14% | 167 |
|
|
2024
Q2 | $393K | Buy |
4,243
+1
| +0% | +$93 | 0.15% | 151 |
|
|
2024
Q1 | $379K | Hold |
4,242
| – | – | 0.15% | 143 |
|
|
2023
Q4 | $379K | Sell |
4,242
-300
| -7% | -$26.8K | 0.16% | 143 |
|
|
2023
Q3 | $332K | Buy |
4,542
+320
| +8% | +$23.4K | 0.11% | 163 |
|
|
2023
Q2 | $527K | Sell |
4,222
-366
| -8% | -$45.7K | 0.18% | 113 |
|
|
2023
Q1 | $350K | Buy |
4,588
+1,277
| +39% | +$97.3K | 0.11% | 156 |
|
|
2022
Q4 | $413K | Sell |
3,311
-105
| -3% | -$13.1K | 0.22% | 75 |
|
|
2022
Q3 | $273K | Buy |
3,416
+105
| +3% | +$8.39K | 0.14% | 97 |
|
|
2022
Q2 | $406K | Sell |
3,311
-15
| -0.5% | -$1.84K | 0.21% | 80 |
|
|
2022
Q1 | $298K | Sell |
3,326
-30
| -0.9% | -$2.69K | 0.15% | 105 |
|
|
2021
Q4 | $374K | Buy |
3,356
+45
| +1% | +$5.02K | 0.18% | 88 |
|
|
2021
Q3 | $417K | Buy |
+3,311
| New | +$417K | 0.23% | 73 |
|